Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Survival Analysis01:21

Cancer Survival Analysis

298
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
298
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

889
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
889
Cancer Therapies02:49

Cancer Therapies

7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Senior management's understanding of and response to climate goals in healthcare: a qualitative study in a Swedish hospital.

BMJ open·2026
Same author

Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities.

Molecular oncology·2025
Same author

Let's Talk About the Elephant in the Room: A Psychological Safety Climate Intervention Among Nursing Teams-A Qualitative Evaluation.

Journal of advanced nursing·2025
Same author

Extending Integration: Interventions Supporting Communication and Collaboration Between Patients with Neurological Diseases, Their Informal Caregivers and Healthcare Staff - a Scoping Review.

International journal of integrated care·2025
Same author

Implementation of a Recovery College Embedded in a Swedish Psychiatry Organization: Qualitative Case Study.

Journal of participatory medicine·2024
Same author

Understanding Co-Creation in a Research Partnership Programme Exploring Patient-Driven Innovations: A Qualitative Longitudinal Study.

Health expectations : an international journal of public participation in health care and health policy·2024

相关实验视频

Updated: May 10, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

1.8K

实施个性化癌症医学:从定性访谈研究的见解

Michele Masucci1,2, Jenny Del Villar Pérez2, Pamela Mazzocato2

  • 1Department of Microbiology Tumor and Cell Biology (MTC), Karolinska Institutet, Biomedicum Q8C, Solnavägen 9, 171 65 Solna, Sweden.

Journal of personalized medicine
|April 25, 2025
PubMed
概括

个性化癌症医学 (PCM) 面临着由于组织和系统障碍的实施挑战. 克服这些需要多方利益相关者的合作和适应性战略,以有效地融入临床实践.

关键词:
癌症 医疗保健 医疗保健癌症研究 癌症研究医疗保健组织 医疗保健组织实施研究研究研究.医疗管理医疗管理个性化癌症药物 个性化癌症药物个性化医疗是个性化的医疗.精准医学是一门精准医学.精确瘤学 精确瘤学翻译研究 翻译研究

更多相关视频

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.7K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.8K

相关实验视频

Last Updated: May 10, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

1.8K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.7K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.8K

科学领域:

  • 在瘤学瘤学.
  • 医疗保健管理的管理
  • 基因组学就是基因组学.

背景情况:

  • 个性化癌症医学 (PCM) 提供基于遗传特征的量身定制治疗.
  • 整合到临床实践中受到组织和系统障碍的阻碍.
  • 这项研究调查了瑞典一家领先的癌症中心的PCM实施因素.

研究的目的:

  • 确定影响个性化癌症医学实施的障碍和促进因素.
  • 探索医疗保健专业人员和管理层对PCM整合的观点.
  • 为在临床环境中成功采用PCM的策略提供信息.

主要方法:

  • 与16名医疗专业人员和管理人员进行了半结构化采访.
  • 使用内容分析来确定与PCM实施相关的关键主题.
  • 定性研究指南 (COREQ) 确保了方法的严格性.

主要成果:

  • PCM被视为一种技术创新和以患者为中心的方法.
  • 确定的障碍包括组织惯性,资金碎片化和股权问题.
  • 促进者包括领导力承诺,跨部门合作和支持性政策.

结论:

  • 成功实施PCM需要通过多方利益相关者的协作克服系统性障碍.
  • 建议建立一个"第三形式组织",将学术界和临床护理联系起来.
  • 适应性治理,政策改革和可持续融资对于PCM整合至关重要.